ALESSANDRI, cristiano
 Distribuzione geografica
Continente #
NA - Nord America 10.439
EU - Europa 3.515
AS - Asia 2.194
AF - Africa 99
SA - Sud America 89
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.345
Nazione #
US - Stati Uniti d'America 10.331
IT - Italia 1.546
SG - Singapore 897
SE - Svezia 602
CN - Cina 572
IN - India 553
FI - Finlandia 338
UA - Ucraina 235
DE - Germania 174
GB - Regno Unito 106
CA - Canada 89
BG - Bulgaria 87
RU - Federazione Russa 77
TG - Togo 72
FR - Francia 70
IE - Irlanda 69
AR - Argentina 67
ID - Indonesia 63
AT - Austria 34
NL - Olanda 34
RO - Romania 34
HK - Hong Kong 27
BE - Belgio 25
CH - Svizzera 14
MX - Messico 14
PL - Polonia 11
KR - Corea 10
BR - Brasile 9
CL - Cile 9
ES - Italia 9
GR - Grecia 9
IL - Israele 9
PH - Filippine 9
TR - Turchia 9
ZA - Sudafrica 9
HU - Ungheria 8
MK - Macedonia 6
MY - Malesia 6
AU - Australia 5
KZ - Kazakistan 5
MA - Marocco 5
SA - Arabia Saudita 5
EG - Egitto 4
EU - Europa 4
IR - Iran 4
JP - Giappone 4
TH - Thailandia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
HR - Croazia 3
LB - Libano 3
LT - Lituania 3
RS - Serbia 3
SC - Seychelles 3
SI - Slovenia 3
VN - Vietnam 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
IQ - Iraq 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BN - Brunei Darussalam 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
JM - Giamaica 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
PA - Panama 1
PE - Perù 1
TM - Turkmenistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 16.345
Città #
Fairfield 1.490
Chandler 969
Ashburn 734
Woodbridge 660
Singapore 649
Rome 570
Dearborn 567
Seattle 548
Houston 520
Cambridge 485
Wilmington 452
Ann Arbor 331
Princeton 310
Plano 240
San Paolo di Civitate 230
Santa Clara 228
Lawrence 197
Millbury 167
Beijing 148
Boston 133
San Diego 130
Helsinki 127
New York 123
Andover 93
Sofia 85
Milan 83
Des Moines 75
Lomé 72
Jacksonville 71
Dublin 69
Federal 63
Jakarta 59
Boardman 55
Toronto 53
San Mateo 49
Fremont 44
Norwalk 44
Moscow 42
Falls Church 37
Vienna 30
Hefei 27
Los Angeles 27
Mannheim 27
Nanjing 27
Southend 24
Falkenstein 23
Hong Kong 23
Kunming 23
Phoenix 23
Brussels 21
Ottawa 21
Guangzhou 20
Monterotondo 18
Bühl 16
Redwood City 16
Latina 15
Palermo 15
Dallas 14
Florence 14
Padova 14
Jinan 13
Shanghai 13
London 12
Stockholm 11
Turin 11
Nanchang 10
Pisa 10
Buffalo 9
Hebei 9
Mexico City 9
Mountain View 9
Pune 9
Sassuolo 9
Tappahannock 9
Warsaw 9
Zhengzhou 9
Athens 8
Bremen 8
Budapest 8
Frankfurt am Main 8
Grafing 8
Naples 8
Zurich 8
Amsterdam 7
Indiana 7
Redmond 7
Auburn Hills 6
Bari 6
Changsha 6
Gangbuk-gu 6
Hangzhou 6
Montréal 6
Munich 6
Paris 6
Santiago 6
Valenza 6
Bologna 5
Catania 5
Frosinone 5
Genova 5
Totale 11.758
Nome #
Validazione della versione italiana del lupus-qol, questionario malattia-specifico per la misurazione della qualità della vita relativa allo stato di salute in pazienti adulti affetti da lupus eritematoso sistemico 212
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 169
Kidney expression of toll like receptors in lupus nephritis: quantification and clinicopathological correlations 130
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs 127
null 127
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 124
Clinical relevance of silent red blood cell autoantibodies. 120
Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome 117
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study 112
Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies 110
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients 105
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients 105
Ultrasonographic Evaluation of Resistive Index and Renal Artery Stenosis in Patients with Anti-phospholipid Syndrome: Two Distinct Mechanisms? 103
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models 102
Treating lupus patients with antimalarials. analysis of safety profile in a single-center cohort 101
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases 100
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus. 100
Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases 99
Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile 98
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 98
Antibodies to age-β2 glycoprotein I in patients with antiphospholipid antibody syndrome. 96
Autophagy induces protein carbamylation in fibroblast-like synoviocytes from patients with rheumatoid arthritis 96
A monocentric cohort of obstetric seronegative anti-phospholipid syndrome 95
Anti-carbonic anhydrase II antibodies in systemic sclerosis: Association with lung involvement 94
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study 94
Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus 92
A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene. 91
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement 91
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: Results from a monocentric cohort 91
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices 88
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13 88
Y chromosome microchimerism in Sjögren's syndrome. 86
Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al. 85
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment 84
Impaired bone matrix glycoprotein pattern is associated with increased cardiometabolic risk profile in patients with type 2 diabetes mellitus 84
The natural agonist of estrogen receptor β silibinin plays an immunosuppressive role representing a potential therapeutic tool in rheumatoid arthritis 84
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 84
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus 84
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome 83
Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts 83
Anti-endothelial cell antibodies in rheumatic heart disease 83
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. 82
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren’s syndrome patients and correlates with focus score and disease activity 82
Autophagy and rheumatoid arthritis: Current knowledges and future perspectives 82
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows 82
BETA2-GLYCOPROTEIN I IS A TARGET OF T CELL REACTIVITY IN PATIENTS WITH ADVANCED CAROTID ATHEROSCLEROTIC PLAQUES 81
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes. 81
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features 80
Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis 80
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 79
CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients 79
Belimumab decreases autophagy and citrullination in peripheral blood mononuclear cells from patients with systemic lupus erythematosus 79
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus 78
Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage 78
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome 78
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 78
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort 78
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus 77
Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti-estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus 77
Nailfold capillaroscopy abnormalities are associated with the presence of anti-endothelial cell antibodies in Sjogren's syndrome 77
TLC immunostaining for detection of "antiphospholipid" antibodies 76
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 76
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus. contribution to disease susceptibility and clinical phenotypes 75
Developing new evaluation methods in systemic lupus erythematosus 75
Castleman's Disease and Autoimmunity 74
Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome 74
Il reumatismo articolare acuto negli anni 2000 74
"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome. 74
Microparticles and autophagy, a new frontier in the understanding of atherosclerosis in rheumatoid arthritis 74
Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression 74
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study 74
['ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants: even and odd]. 73
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 73
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis 73
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome 72
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 72
The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus. 72
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis 72
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus 72
Identification of subclinical lung involvement in ACPA-positive subjects through functional assessment and serum biomarkers 72
Comprehensive disease control in systemic lupus erythematosus 72
Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis 71
Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-onset Still's Disease and Sepsis. 71
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX 71
Pregnancy outcome in systemic lupus erythematosus patients. a monocentric cohort analysis 71
Cardiac involvement in patients with Wegener's granulomatosis 70
Treatment with gonadotropin releasing hormone agonists in systemic lupus erythematosus patients receiving cyclophosphamide: a long-term follow-up study 70
Autophagy modulation in lymphocytes from COVID-19 patients. new therapeutic target in SARS-COV-2 infection 70
Frequency of antibodies to mutated citrullinated vimentin in chronic obstructive pulmonary disease: comment on the article by Demoruelle et al 69
Citrullination and autophagy 69
SERUM sFas/sFasL RATIO IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A FUNCTION OF AGE 68
Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells 68
Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis 67
IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity 67
Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis 67
Lymph node IL-18 expression in adult-onset Still's disease 66
Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes 66
New autoantigens in the antiphospholipid syndrome 65
Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis 65
Serum sclerostin as a possible biomarker in ankylosing spondylitis. a case-control study 65
Totale 8.562
Categoria #
all - tutte 61.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.267 0 0 0 0 0 687 542 337 305 214 109 73
2020/20211.377 113 161 41 58 38 62 29 131 237 282 125 100
2021/20223.268 51 183 310 194 391 129 69 319 232 272 508 610
2022/20233.446 625 793 194 357 350 376 42 224 263 54 127 41
2023/20241.785 82 229 79 110 128 233 101 160 33 248 197 185
2024/20251.747 155 250 253 408 300 381 0 0 0 0 0 0
Totale 17.073